Epigenetic inactivation of the human sprouty (hSPRY2) homologue in prostate cancer

Oncogene

Volumn 24, Issue 13, 2005, Pages 2166-2174

  McKie, Arthur B ^a   Douglas, David A ^a   Olijslagers, Sharon ^a   Graham, Julia ^a   Omar, Mahmoud M ^a   Heer, Rakesh ^a   Gnanapragasam, Vincent J ^a   Robson, Craig N ^a   Leung, Hing Y ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

CpG; Hypermethylation; Island; Prostate cancer; Sprouty (modulator); Tumour suppressor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; COMPLEMENTARY DNA; LUCIFERASE; MESSENGER RNA; PROTEIN; PROTEIN TYROSINE KINASE; SPRY2 PROTEIN; UNCLASSIFIED DRUG; PRIMER DNA; SPRY2 PROTEIN, HUMAN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSURETHRAL RESECTION; CHROMOSOME 3; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOSITY LOSS; PROSTATE TUMOR; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 3; DNA METHYLATION; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MALE; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; PROTEINS;

EID: 16444370423     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208371     Document Type: Article

References (24)

1. Casci T, Vinos J and Freeman M. (1999). Cell, 96, 655-665.
2. Christofori G. (2003). Nat. Cell Biol., 5, 377-379.
3. Dikic I and Giordano S. (2003). Curr. Opin. Cell Biol., 15, 128-135.
4. Ding W, Bellusci S, Shi W and Warburton D. (2003). Gene, 223, 175-185.
5. Djakiew D. (2000). Prostate, 42, 150-160.
6. Dong JT, Boyd JC and Frierson HF. (2001). Prostate, 49, 166-171.
7. Dorkin TJ, Robinson MC, Marsh C, Bjartell A, Neal DE and Leung HY. (1999). Oncogene, 18, 2755-2761.
8. Hacohen N, Kramer S, Sutherland D, Hiromi Y and Krasnow MA. (1998). Cell, 92, 253-263.
9. Hanafusa H, Torii S, Yasunaga T and Nishida E. (2002). Nat. Cell Biol., 4, 850-858.
10. Ittman M and Mansukhani A. (1997). J. Urol., 157, 351-356.
11. Jones PA and Takai D. (2001). Science, 293, 1068-1070.
12. Lim J, Yusoff P, Wong ESM, Chandramouli S, Lao D-H, Fong CW and Guy GR. (2002). Mol. Cell. Biol., 22, 7953-7966.
13. Maegawa S, Yoshioka H, Itaba N, Kubota N, Nishihara S, SHirayoshi Y, Nanba E and Oshimura M. (2001). Mol. Carcinogen., 31, 1-9.
14. McKie AB, McHale JC, Keen TJ, Tartelin EE, Goliath R, Lithe-Verhoeven JJ, Greenberg J, Ramesar RS, Hoyng CB, Cremers FPM, Mackey DA, Bhattacharya SS, Bird AC, Markham AF and Inglehearn CF. (2001). Hum. Mol. Genet., 10, 1555-1562.
15. Nguyen C, Liang G, Nguyen TT, Tsao-Wei D, Groshen S, Lubbert M, Zhou JH, Benedict WF and Jones PA. (2001). J. Natl. Cancer Inst. (Bethesda), 93, 1465-1472.
16. Park M and Peschard P. (2003). Cancer Cell, 3, 519-523.
17. Pettaway CA, Pathok S, Greene G, Ramirez E, Wilson MR, Killion JT and Fidler IJ. (1996). Clin. Cancer Res., 2, 1627-1636.
18. Reich A, Sapir A and Shilo B-Z. (1999). Developement, 126, 4139-4147.
19. Rubin C, Litvak V, Medvedovsky H, Zwang Y, Lev S and Yarden Y. (2003). Curr. Biol., 13, 297-307.
20. Sasaki A, Taketomi T, Kato R, Saeki K, Nonami A, Sasaki M, Kuriyama M, Saito N, Shibuya M and Yoshimura A. (2003). Nat. Cell Biol., 5, 427-432.
21. Takai D and Jones PA. (2002). Proc. Natl. Acad. of Sci. USA, 99, 3740-3745.
22. Thellin O, Zorsi W, Lakaye B, Borman B, Coumans B, Hennen G, Grisar T, Igout A and Keinen E. (1999). J. Biotechnol., 75, 291-295.
23. Wong ESM, Fong CW, Lim J, Yusoff P, Low BC, Langdon WY and Guy GR. (2002). EMBO J., 21, 4796-4808.
24. Yusoff P, Lao D-H, Ong SH, Wong ESM, Lim J, Lo TL, Leong HF, Fong CW and Guy GR. (2002). J Biol Chem., 227, 3195-3201.